Research and development expense (includes related party amounts of 975 for the three and six months ended june 30, 2026 and 0 for the three and six months ended june 30, 2025)
3,342,000
4,582,000
8,738,500*
9,539,000
General and administrative expense
2,931,000
4,726,000
3,912,500*
4,250,000
Total operating expenses
6,273,000
9,308,000
12,651,000*
13,789,000
Income (loss) from operations
227,000
-9,308,000
-10,651,000*
-13,789,000
Interest income
16,000
37,000
294,000*
133,000
Gain (loss) on warrant liability
220,000
2,674,000
3,628,000*
-2,119,000
Gain on ppas liability
0
273,000
-101,500*
-
Other expense
11,000
20,000
-1,043,000*
3,000
Total other income (expense)
225,000
2,964,000
2,777,500*
-1,989,000
Net income (loss) and comprehensive income (loss)
452,000
-6,344,000
-7,873,500
-15,778,000
Basic EPS
0.27
-4.22
-0.133
-0.27
Diluted EPS
0.27
-4.22
-0.133
-0.27
Basic Average Shares
1,660,586
1,501,649
59,234,063
58,745,343
Diluted Average Shares
1,661,709
1,501,649
59,234,063
58,745,343
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Time Plot
Show the time plot by selecting a row from the table.